Technology News and Research

RSS

Labopharm first quarter total revenue increases to $5.3 million

Labopharm Inc. today reported its progress and financial results for the first quarter ended March 31, 2011.

4 May 2011

Affitech, Cancer Research Technology sign deal to advance therapeutic antibodies

Cancer Research Technology, the commercial arm of Cancer Research UK, has signed a license agreement to grant antibody medicines company, Affitech A/S, exclusive rights to a CRT patent application and relevant know how to develop and use therapeutic antibodies that recognise and block the function of CCR4, a protein found on certain tumours - including early and late stage cervical cancer and oesophageal cancer.

4 May 2011

ACO rule draws tough questions, highlights system's shortcomings

CQ HealthBeat reports that federal officials are considering the public criticism and comments they are receiving in response to the proposed rule issued regarding the health law's accountable care organizations. One expert, for instance, tells Politico Pro that data collection challenges could impede the formation of ACOs.

4 May 2011

Almac launches six enzyme screening kits

As anticipated, Almac's biocatalysis business has expanded from its 2009 launch with the sale of six enzyme screening kits, to the current supply of 100s of kgs of chiral intermediates for drug substance manufacture, regular enzyme supply to specialty chemical companies and continued growth of its screening kits offering. Biocatalysis is increasingly recognised as an alternative solution for solving complex chemistry problems due to its rapid implementation, economic benefits and 'green' reputation.

4 May 2011

Top 10 gadget gifts for Mother's Day 2011

ElderGadget.com, the only website devoted to news, reviews, and information on the hottest consumer electronics with senior-friendly features, announces its top ten technology gifts for mom, sure to have a gadget she will find fun to own and easy to use.

From Garmin 4 May 2011

ChipDX identifies gene expression signature in early-stage breast tumors

ChipDX LLC, a New York-based molecular diagnostics and personalized medicine research company, has discovered a gene expression signature present in the cells of early-stage breast tumors that indicates the chance of the tumor recurring within 10 years.

4 May 2011

UW School of Pharmacy receives Dohmen donation to enhance students' education

Dohmen Company CEO Cynthia LaConte announced today that the Dohmen Company Foundation, the philanthropic arm of the 153-year-old healthcare services company, has donated $100,000 to the University of Wisconsin-Madison School of Pharmacy.

4 May 2011

RaySearch Laboratories reports net sales of SEK 23.0 M for 2011

RaySearch Laboratories: "We have already noted a growing interest in RayStation® following the breakthrough in the US and Europe, and I am convinced that our customer list will grow during 2011," concludes Johan Löf.

4 May 2011

FDA clears Sectra's digital mammography system

Women in the US will now have the same opportunity as million of European women already have; to undergo mammography with significantly lower radiation dose. This is the result of FDA's clearance of the Swedish IT and medical technology company Sectra's digital mammography system, Sectra MicroDose Mammography.

4 May 2011

Health IT can reduce greenhouse gas emissions and produce environmental savings

An analysis by Kaiser Permanente shows that use of health information technology can dramatically reduce greenhouse gas emissions and produce other important environmental savings.

4 May 2011

Opinions: U.S. development aid, commitment to women; R&D partnerships and development

Once again, Save the Children's State of the World's Mothers report has ranked Afghanistan, where one in 11 women die of complications related to pregnancy and childbirth, the worst place in the world to be a mother, which "is not surprising," Ret. Army Col. John Agoglia, who served as director of the Counterinsurgency Training Center-Afghanistan in Kabul from 2008-2010, writes in a Politico opinion piece.

4 May 2011

Boston Scientific reports first use in Europe of Blazer Open-Irrigated Catheter

Boston Scientific Corporation today announced CE Mark approval and first use in Europe of its Blazer™ Open-Irrigated Catheter, the Company's latest radiofrequency ablation (RFA) catheter designed to treat a variety of arrhythmias such as atrial fibrillation, atrial flutter, ventricular tachycardia and other supraventricular tachycardias. The product is being launched this quarter in select CE Mark countries.

4 May 2011

Immunetics receives NIH grant for new confirmatory test trial in Chagas' disease

Immunetics, Inc. today announced it has been awarded a $2.4 million, 3-year Phase II SBIR grant by the National Institute of Allergy and Infectious Diseases, a division of the National Institutes of Health, to support clinical trials of the company's new confirmatory test for Chagas' disease, a serious and potentially fatal parasitic infection.

4 May 2011